Tag: VTVT

Blue Horseshoe Stocks: Options Review & More

Post Earnings Options Review

Our premarket report on Friday focused on two sets of options ideas from companies which had just posted earnings beats that morning. As it turns out, there was a big time opportunity in each of them.

General Electric Co. GE – We signaled the GE Weekly $14-15 Calls, and it was the $14 and $14.50’s that produced solid chances to profit from that idea. The $14’s ran 106% from .36-.74, and the $14.50 really shined with a move from .03 to .25, a whopping gain of 733%
___

HoneyWell International, Inc. HON – We also highlighted our interest in tracking the HON Weekly $150 & $152.50 Calls for possible day-trades, and while the 152.50’s didnt see a lot of action, the $150’s were a perfect idea, trading in a mind boggling range from .01 to .52, a 5100% single session gain! Big cheers to anyone who caught a piece of that action!

Hasbro, Inc. HAS

Hasbro came out with their quarterly earning report which disappointed, according to the company, because of the Toys ‘R Us shutdown. The stock had already registered a new 52 week low on Friday after nearly two months of backsliding, and we’re still thinking it has a ways to fall.

That’s why we’re going to adopt a bearish stance and signal the HAS Weekly $78-76 Puts to start of this new trading week.

Extended Watchlist:
AGMH, SGYP, EBIO, ISIG, SLDB, VTVT, MYSZ, DLSV

Blue Horseshoe Stocks: VTVT New Highs & More

vTv Therapeutics, Inc. VTVT

We’ve been closely tracking VTVT since including it our report on Tuesday morning as a bottom play. As we mentioned yesterday, the timing was essentially perfect. It took off on Tuesday, and yesterday that run persisted just as we suggested it may.

The stock traded in a range from 1.24 to a new high of 2.67 yesterday, representing an intraday move of 115% From Tuesday’s low of .79 the stock has registered a two-day upswing of 238% and has easily been the NASDAQ’s top play of the week.

Onconova Therapeutics, Inc. ONTX

Speaking of bottom plays, we’re always searching for the next heavily oversold stock, and we’ve got a candidate to bring forth today in ONTX. As you can plainly view on the chart snapshot below, the stock has been heavily sold off, and the RSI is definitely giving off that heavily oversold signal.

The last time that happened the stock did mount an appreciable recovery in the ensuing weeks, so we’re going to put ONTX on extended watch.

Extended Watchlist:
AXXA, IMTV, HMNY, AREX, AYTU, IRBT, AVGR

Blue Horseshoe Stocks: VTVT Recap & More

vTv Therapeutics, Inc. VTVT

Our report yesterday morning included  a look at the VTVT chart, and establishing our interest in tracking it as a bottom play. Our timing in this really could not have been any better as the stock not only made it biggest single session move of the year, but also traded its highest volume.

VTVT ran from a low of .79 and reached as high as 1.67, a 53% intraday rip, and ended up closing at 1.19, filling a portion of the large gap which you can plainly see below. Based on the activity we’ve now witnessed, and the still-ripe look of the chart, we’re going to continue to keep a close watch over VTVT.

Van Eck Vectors Gold Miners ETF (GDX)

We also want to begin tracking a pair of options contracts in the GDX chain. Gold has been doing well and looks as if another solid day could be in the cards.

On that event, there should be some nice activity in the GDX Weekly $22.50 & $23 Calls, so we’ll be monitoring for that.


Tandem Diabetes Care, Inc. TNDM – Update

It was a week ago today that we were commenting on our coverage of TNDM in 2018. We caught this stock at a low of 2.14 earlier this year, and it has come a long way since then.

This week the stock has traded up to a high of 7.75, marking an increase of 262% since we began tracking it.

Extended Watchlist:
TEUM, ARQL, SPWR, PRPO, INPX, USLV, OAS